A massive genetic analysis of over one million people has revealed that APOE, long known for its role in Alzheimer’s disease, also independently increases a person’s risk of delirium. The researchers found that this effect cannot be explained solely by dementia, showing that APOE directly contributes to delirium vulnerability in otherwise cognitively healthy individuals.
